Australia faces a potential tariff of between 2 per cent and 8 per cent on the $30 billion of exports sold to the United ...

Otsuka’s Taiho Pharmaceutical is paying $400 million upfront to acquire Switzerland’s Araris Biotech and its antibody-drug ...

During the pandemic, hospitals expanded the amount of 340B revenue they took in by partnering with other pharmacies, and drug makers retaliated by limiting those partnerships.

Taiho Pharmaceutical has agreed to acquire Swiss-based antibody-drug-conjugate (ADC) specialist Araris Biotech for up to ...

Collegium also announced today the appointments of three new executive leaders as the Company drives a new phase of growth: David Dieter, as Executive Vice President, General Counsel; Jane Gonnerman ...

Get the latest updates on the most important stories from across the nation. From political developments and economic trends ...

Abdul Muktadir, chairman and managing director of Incepta Pharmaceuticals Ltd, has been elected president of the Bangladesh ...

Who could have thought that having your seat mixed up can lead you to the love of your life?  Onyeka and Obi’s journey began ...

The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...

We are the problem when we would rather take the injection or the pill than make the lifestyle change. I am fortunate that I ...

Swiss pharmaceutical giant Novartis will watch "very carefully" how the reciprocal tariff policy proposed by the United ...

Last year, Novartis agreed to buy U.S.-based Mariana Oncology for $1 billion upfront to expand its portfolio of the drugs, ...